including revenue from its hybrid cloud platform, Red Hat software, consulting services, and product sales to Kyndryl.
In its first quarter ended March 31, IBM reported revenue of $14.20 billion, up nearly 8 percent year over year. Net income, however, declined more than 23 percent to $733 million.
In January IBM struck a deal to sell its health-care data and analytics assets, including Health Insights, MarketScan and Micromedex, to global investment firm Francisco Partners